Keywords: biomarin, genzyme, conduct, additional, ph, iii, aldurazyme

BioMarin and Genzyme to conduct additional Ph III Aldurazyme trial

Article | 24 November 1999

Print This

The US Food and Drug Administration has requested that BioMarinPharmaceutical and Genzyme General conduct an additional Phase III trial of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in